These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 16531952)

  • 1. Candidal bloodstream infection: will prevention work?
    Lum LC
    Pediatr Crit Care Med; 2006 Mar; 7(2):184-5. PubMed ID: 16531952
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral amphotericin B for the prevention of Candida bloodstream infection in critically ill children.
    Ben-Ari J; Samra Z; Nahum E; Levy I; Ashkenazi S; Schonfeld TM
    Pediatr Crit Care Med; 2006 Mar; 7(2):115-8. PubMed ID: 16474259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive candidiasis: turning risk into a practical prevention policy?
    Sobel JD; Rex JH
    Clin Infect Dis; 2001 Jul; 33(2):187-90. PubMed ID: 11418878
    [No Abstract]   [Full Text] [Related]  

  • 4. Candidemia in the surgical intensive care unit.
    Krcmery VC; Babela R
    Clin Infect Dis; 2002 Jun; 34(11):1537-8. PubMed ID: 12015705
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative evaluation of antifungal agents in the prevention of tetracycline-induced candidiasis of gastrointestinal tract.
    Mehta AB; Mahajam HR; Vora DD; Shah AC; Agarwala AB
    J Assoc Physicians India; 1970 Jul; 18(7):621-6. PubMed ID: 5473877
    [No Abstract]   [Full Text] [Related]  

  • 6. Neonatal systemic candidiasis. A 14-year review.
    Al-Khayat A; Koutouby A; Habibullah J; El-Atawi K
    Saudi Med J; 2004 Oct; 25(10):1505-7. PubMed ID: 15494838
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of central venous catheter fungal infection using liposomal amphotericin-B lock therapy.
    Buckler BS; Sams RN; Goei VL; Krishnan KR; Bemis MJ; Parker DP; Murray DL
    Pediatr Infect Dis J; 2008 Aug; 27(8):762-4. PubMed ID: 18664989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of antifungals in the surgical intensive care unit: a multi-institutional study.
    Garey KW; Neuhauser MM; Bearden DT; Cannon JP; Lewis RE; Gentry LO; Kontoyiannis DP
    Mycoses; 2006 May; 49(3):226-31. PubMed ID: 16681815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasive fungal infections caused by Candida and Malassezia species in the neonatal intensive care unit.
    Devlin RK
    Adv Neonatal Care; 2006 Apr; 6(2):68-77; quiz 78-9. PubMed ID: 16618476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention and treatment of invasive fungal infection in very low birthweight infants.
    Brecht M; Clerihew L; McGuire W
    Arch Dis Child Fetal Neonatal Ed; 2009 Jan; 94(1):F65-9. PubMed ID: 18838467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiological characteristics of fatal Candida krusei fungemia in immunocompromised febrile neutropenic children.
    Agirbasli H; Otlu B; Bilgen H; Durmaz R; Gedikoglu G
    Infection; 2008 Feb; 36(1):88-91. PubMed ID: 18084719
    [No Abstract]   [Full Text] [Related]  

  • 12. Nosocomial candidemia: an ounce of prevention is better than a pound of cure.
    Diekema DJ; Pfaller MA
    Infect Control Hosp Epidemiol; 2004 Aug; 25(8):624-6. PubMed ID: 15357151
    [No Abstract]   [Full Text] [Related]  

  • 13. Experimental candidosis. Pathogenesis, prevention, therapy.
    Segal E
    Mycoses; 1999; 42 Suppl 2():55-9. PubMed ID: 10865905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preterm neonates with candidal brain microabscesses: a case series.
    Pahud BA; Greenhow TL; Piecuch B; Weintrub PS
    J Perinatol; 2009 Apr; 29(4):323-6. PubMed ID: 19325555
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention of invasive Candida infections in preterm infants: the time is now.
    Kaufman DA
    Expert Rev Anti Infect Ther; 2008 Aug; 6(4):393-9. PubMed ID: 18662105
    [No Abstract]   [Full Text] [Related]  

  • 16. Candidiasis in an intensive care unit.
    Potgieter PD; Hammond J
    S Afr J Surg; 1994 Mar; 32(1):17. PubMed ID: 11218436
    [No Abstract]   [Full Text] [Related]  

  • 17. Fungal infections in neonates: update on prevention and treatment.
    Kaufman DA
    Minerva Ginecol; 2007 Jun; 59(3):311-29. PubMed ID: 17576407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: substudy of a randomized double-blind trial.
    Queiroz-Telles F; Berezin E; Leverger G; Freire A; van der Vyver A; Chotpitayasunondh T; Konja J; Diekmann-Berndt H; Koblinger S; Groll AH; Arrieta A;
    Pediatr Infect Dis J; 2008 Sep; 27(9):820-6. PubMed ID: 18679151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of the dosage of flucytosine in combination with amphotericin B for disseminated candidiasis: a pharmacodynamic rationale for reduced dosing.
    Hope WW; Warn PA; Sharp A; Reed P; Keevil B; Louie A; Walsh TJ; Denning DW; Drusano GL
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3760-2. PubMed ID: 17682101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal prophylaxis for the prevention of neonatal candidiasis?
    O'Grady MJ; Dempsey EM
    Acta Paediatr; 2008 Apr; 97(4):430-3. PubMed ID: 18363952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.